New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ABBV From The Last 14 Days
Check below for free stories on ABBV the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 1, 2014
07:47 EDTABBVAbbVie cheapest Pharma stock under coverage, says Jefferies
Subscribe for More Information
July 28, 2014
10:02 EDTABBVOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:40 EDTABBVAbbVie should be bought on weakness, says BMO Capital
Subscribe for More Information
05:36 EDTABBVAbbVie upgraded to Buy from Neutral at UBS
Subscribe for More Information
July 25, 2014
09:20 EDTABBVAbbVie only gave prepared remarks and no Q&A, citing UK code restrictions
09:19 EDTABBVAbbVie sees Q3 revenue growth in low to mid single digits, consensus $4.75B
Subscribe for More Information
09:17 EDTABBVAbbVie sees FY14 global Humira sales to see double digit growth
Subscribe for More Information
07:50 EDTABBVAbbVie reports Q2 Global HUMIRA sales up 26.2% to $3.29B
Total company sales growth was also driven by strong growth from key products including Synthroid, Sevoflurane and Duodopa.
07:48 EDTABBVAbbVie sees Q3 adjusted EPS 77c-79c, consensus 77c
07:48 EDTABBVAbbVie backs FY14 adjustd EPS $3.06-$3.16, consensus $3.14
Subscribe for More Information
07:47 EDTABBVAbbVie reports Q2 adjusted EPS 82c, consensus 76c
Subscribe for More Information
07:31 EDTABBVEMA recommends expanded indication for Humira
Subscribe for More Information
July 24, 2014
12:56 EDTABBVPerrigo confirms AB therapeutic equivalent rating for testosterone gel 1.0%
Subscribe for More Information
July 21, 2014
10:27 EDTABBVUBS pharma and federal affairs analysts hold an analyst/industry conference call
Subscribe for More Information
08:01 EDTABBVAbbVie acquisition positive, says Argus
Subscribe for More Information
07:59 EDTABBVShire downgraded to Market Perform from Outperform at Leerink
Leerink downgraded Shire (SHPG) on Friday to Market Perform citing the takeover by AbbVie (ABBV) as it does not expect competitive bids to emerge.
06:43 EDTABBVGrowing market for hepatitis-C treatment prompts legal scramble, WSJ says
Subscribe for More Information
06:10 EDTABBVStocks with implied volatility movement; ABBV JOY
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use